The Effect of Hepatosteatosis on Response to Antiviral Treatment in Patients with Chronic Hepatitis B: A Meta-Analysis

Table 1

Characteristics of the studies included in this meta-analysis.

Study	Year	Location	Sample size	Number; included in; the analysis	Age-matched	Sex-matched	Follow-up; (weeks)	Therapy regimen	Therapy period	Diagnosis method	Quality scores
Cindoruk et al. [16]	2002–2006	Turkey	140	98	Yes	Yes	48	Peg-IFN alfa-2a; 180 μg/week or; Peg-IFN alfa-2b; 80 μg/week and; LAM 100 mg/d	48	Histopathology	7
Ates et al. [13]	2006–2009	Turkey	84	84	No	Yes	96	Peg-IFN alfa-2a; 180 μg/week or; Peg-IFN alfa-2b; 80 μg/week	48	Histopathology	6
Shi et al. [19]	2007-2008	China	120	96	No	Yes	48	Peg-IFN alfa-2a; 180 μg/week or; Peg-IFN alfa-2b; 80 μg/week	48	Histopathology	6
Jin et al. [18]	2007–2009	China	267	213	Yes	Yes	96	ETV 0.5 mg/d	96	Ultrasound	9
Chen et al. [14]	2007–2009	China	332	316	Yes	Yes	96	LAM 100 mg/d and; ADV 10 mg/d or; ETV 0.5 mg/d	96	Ultrasound	8
Chen et al. [15]	2006–2012	China	141	141	Yes	Yes	96	ETV 0.5 mg/d	96	Ultrasound	7
Gong et al. [17]	2010–2013	China	97	89	No	Yes	96	Peg-IFN alfa-2a; 180 μg/week	48	Histopathology	6
Xu et al. [20]	2005–2009	China	50	50	Yes	No	48	Peg-IFN alfa-2a; 180 μg/week	48	Histopathology	6